PROCR
PROCR (protein C receptor), also known as EPCR, CCD41 and CD201, is a membrane receptor that binds activated protein C. It enhances protein C activation and contributes to the protein C pathway that controls blood coagulation. Browse Assay Genie's current range of PROCR research reagents below, or read on for the biology behind the target.
PROCR, the endothelial protein C receptor, binds activated protein C, a serine protease that is itself activated by and involved in the blood coagulation pathway. PROCR also enhances protein C activation by the thrombin-thrombomodulin complex, and so plays a role in the protein C pathway that controls blood coagulation. Researchers studying anticoagulant signalling, haemostasis and vascular biology therefore use the PROCR protein and its ligand interactions as a reference point.
The PROCR gene encodes an N-glycosylated type I membrane protein. HGNC classifies it within the CD molecules, and it is also designated CD201. The same protein appears in the literature under the names EPCR and CCD41. Its previous HGNC name was protein C receptor, endothelial. Orthologous genes are named Procr in both mouse and rat, which allows the pathway to be examined in rodent models.
Variation in PROCR has been linked to disease. Mutations in this gene have been associated with venous thromboembolism and myocardial infarction, as well as with late foetal loss during pregnancy. The encoded protein may also play a role in malarial infection and has been associated with cancer. These links make PROCR relevant to studies that extend beyond coagulation, including thrombosis, pregnancy complications, infectious disease and tumour biology. Whether you are running a PROCR ELISA kit, probing expression with a PROCR antibody or characterising the receptor in cell systems, the biology centres on its role in the protein C pathway.
PROCR binds activated protein C and enhances protein C activation, placing it within the pathway that controls blood coagulation.
Mutations in PROCR have been associated with venous thromboembolism and myocardial infarction, making it a target for thrombotic disease studies.
PROCR mutations have been associated with late foetal loss during pregnancy, prompting investigation of the receptor in obstetric outcomes.
The encoded protein may play a role in malarial infection and has been associated with cancer, opening areas for further study.
PROCR is a receptor for activated protein C. It enhances protein C activation by the thrombin-thrombomodulin complex and plays a role in the protein C pathway that controls blood coagulation. It is an N-glycosylated type I membrane protein.
PROCR is also known as EPCR (endothelial protein C receptor), CCD41 and CD201. HGNC lists the approved name as protein C receptor, and the previous name as protein C receptor, endothelial. Check which alias a publication uses when searching the literature.
Mutations in PROCR have been associated with venous thromboembolism, myocardial infarction and late foetal loss during pregnancy. It may also play a role in malarial infection and has been associated with cancer. Mouse and rat both carry a Procr ortholog; check the datasheet of any product for its validated reactivity.
Other coagulation pathway proteins, CD molecules and thrombosis-related targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UNN8; product specifications from Assay Genie datasheets.